SCHEMBL16557433

SCHEMBL16557433

CCOC(=O)CN(c1cc(C)ccc1C)S(=O)(=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ TEAD1 P28347 1/20 0.54
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ KEAP1 Q14145 3/20 0.49
▸ NFE2L2 Q16236 3/20 0.49
▸ LMNA P02545 3/20 0.48
▸ USP2 O75604 2/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ HCRTR2 O43614 2/20 0.47
▸ HPGD P15428 1/20 0.47
▸ TP53 P04637 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ HCRTR1 O43613 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16557451 0.92 POLB (0.52) POLBALDH1A1TEAD1MEN1KMT2A
SCHEMBL16557448 0.89 POLB (0.58) POLBALDH1A1TEAD1MEN1KMT2A
SCHEMBL16438045 0.88 HCRTR2 (0.59) POLBALDH1A1TEAD1MEN1KMT2A
SCHEMBL16557592 0.87 KEAP1 (0.59) POLBALDH1A1TEAD1KEAP1NFE2L2
SCHEMBL16557437 0.86 KEAP1 (0.65) POLBALDH1A1TEAD1MEN1KMT2A
SCHEMBL16557443 0.86 ALDH1A1 (0.52) POLBALDH1A1TEAD1MEN1KMT2A
SCHEMBL16557610 0.80 KEAP1 (0.56) POLBKEAP1NFE2L2HPGD
SCHEMBL16557455 0.78 LMNA (0.67) POLBALDH1A1LMNASMN1; SMN2HPGD
SCHEMBL16557608 0.77 KEAP1 (0.61) POLBKEAP1NFE2L2SMN1; SMN2HPGD
SCHEMBL15583928 0.77 TSHR (0.66) POLBALDH1A1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790233-B2 Compositions and methods of modulating 15-PGDH activity CASE WESTERN RESERVE UNIVERSITY (US) 2017-10-17 — — US disclosed
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2017-06-15 — — US disclosed
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2015-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170165241-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS POLB 1826/4885ALDH1A1 415/4885TEAD1 2549/4885
US-20150072998-A1 COMPOSITIONS AND METHODS OF MODULATING 15-PGDH ACTIVITY PTGS1, HPGD, PTGIS POLB 1826/4885ALDH1A1 415/4885TEAD1 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback